Jolene Louise Lowe Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 909 S 2nd St, Hiawatha, KS 66434 Phone: 785-742-7113 |
Dallis Joseph Schober Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 909 S 2nd St, Hiawatha, KS 66434 Phone: 785-742-7113 |
Lanie Guynn, LMSW, LMAC Counselor - Addiction (Substance Use Disorder) Medicare: Accepting Medicare Assignments Practice Location: 909 S 2nd St, Hiawatha, KS 66434 Phone: 785-742-7113 |
Mr. Mark Russell Ireland, LPC, LMAC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 909 S 2nd St, Hiawatha, KS 66434 Phone: 785-742-7113 |
Brenda June Fitz-simmons, LMSW, CADC1, SAP Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 909 S 2nd St, Hiawatha, KS 66434 Phone: 785-742-7113 Fax: 785-742-3085 |
Celene Frances Haverkamp, CADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 909 S 2nd St, Hiawatha, KS 66434 Phone: 785-742-7113 Fax: 785-742-3085 |
Vivian Elena Mosier Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 909 S 2nd St, Hiawatha, KS 66434 Phone: 785-742-7113 |
Larry Elliott Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 909 S 2nd St, Hiawatha, KS 66434 Phone: 785-742-7113 |
News Archive
Blain Shelton, a 42-year-old Texas man was swimming around 200 yards off the shore of Boliver Island near Galveston on 9th of August when he encountered a shark.
Intensive treatment to lower systolic (top number) blood pressure to below 120 would prevent 107,500 deaths per year in the United States, according to a study by researchers at Loyola University Chicago and other centers.
While overall emergency department use in Massachusetts continues to rise, the number of low-severity visits dropped slightly since the implementation of the state's health care reform law, according to an Annals of Emergency Medicine study published online.
Two widely used targeted therapy drugs approved by the FDA for the treatment of metastatic kidney cancer—sorafenib and sunitinib—are no more effective than a placebo in preventing return of the disease to increase life spans of patients suffering from advanced kidney cancer after surgery, according to a new multi-institutional study in the Lancet led by a researcher at the Abramson Cancer Center (ACC) of the University of Pennsylvania.
A letter was sent to the White House by more than 50 organizations demanding that the administration require simple, standardized health insurance forms starting next year, as called for in the law. Also in the news, Politico Pro reports on a political fight brewing in Michigan over the health law's medical-loss ratio requirements.
› Verified 1 days ago